Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age a… Read more
Vertex Pharmaceuticals Inc (VRTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.072x
Based on the latest financial reports, Vertex Pharmaceuticals Inc (VRTX) has a cash flow conversion efficiency ratio of 0.072x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.24 Billion) by net assets ($17.32 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vertex Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Vertex Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vertex Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vertex Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chubb Ltd
NYSE:CB
|
0.060x |
|
TotalEnergies SE
PINK:TTFNF
|
0.071x |
|
Enbridge Inc
NYSE:ENB
|
0.047x |
|
Intesa Sanpaolo SpA PK
PINK:ISNPY
|
0.011x |
|
UBS Group AG
NYSE:UBS
|
-0.043x |
|
Palo Alto Networks Inc
NASDAQ:PANW
|
0.204x |
|
McKesson Corporation
NYSE:MCK
|
-12.444x |
|
Schneider Electric SE
PINK:SBGSF
|
0.202x |
Annual Cash Flow Conversion Efficiency for Vertex Pharmaceuticals Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Vertex Pharmaceuticals Inc from 1991 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $18.67 Billion | $3.63 Billion | 0.195x | +748.08% |
| 2024-12-31 | $16.41 Billion | $-492.60 Million | -0.030x | -114.92% |
| 2023-12-31 | $17.58 Billion | $3.54 Billion | 0.201x | -32.22% |
| 2022-12-31 | $13.91 Billion | $4.13 Billion | 0.297x | +13.41% |
| 2021-12-31 | $10.10 Billion | $2.64 Billion | 0.262x | -30.12% |
| 2020-12-31 | $8.69 Billion | $3.25 Billion | 0.375x | +45.23% |
| 2019-12-31 | $6.09 Billion | $1.57 Billion | 0.258x | -9.96% |
| 2018-12-31 | $4.44 Billion | $1.27 Billion | 0.286x | -30.77% |
| 2017-12-31 | $2.04 Billion | $844.94 Million | 0.414x | +134.49% |
| 2016-12-31 | $1.34 Billion | $236.10 Million | 0.176x | +152.76% |
| 2015-12-31 | $1.09 Billion | $-365.43 Million | -0.334x | +28.46% |
| 2014-12-31 | $1.10 Billion | $-513.20 Million | -0.467x | -1129.56% |
| 2013-12-31 | $1.36 Billion | $-51.57 Million | -0.038x | -117.52% |
| 2012-12-31 | $1.23 Billion | $267.84 Million | 0.217x | +45.75% |
| 2011-12-31 | $965.51 Million | $143.74 Million | 0.149x | +111.81% |
| 2010-12-31 | $503.97 Million | $-635.44 Million | -1.261x | -223.29% |
| 2009-12-31 | $1.10 Billion | $-427.59 Million | -0.390x | +58.87% |
| 2008-12-31 | $238.87 Million | $-226.48 Million | -0.948x | -1.88% |
| 2007-12-31 | $271.30 Million | $-252.48 Million | -0.931x | -1994.95% |
| 2006-12-31 | $505.94 Million | $-22.48 Million | -0.044x | +93.82% |
| 2005-12-31 | $239.18 Million | $-172.05 Million | -0.719x | +82.07% |
| 2004-12-31 | $35.44 Million | $-142.16 Million | -4.011x | -361.47% |
| 2003-12-31 | $192.84 Million | $-167.62 Million | -0.869x | -313.72% |
| 2002-12-31 | $378.58 Million | $-79.54 Million | -0.210x | -1136.94% |
| 2001-12-31 | $475.35 Million | $-8.07 Million | -0.017x | +64.72% |
| 2000-12-31 | $345.76 Million | $-16.64 Million | -0.048x | +68.33% |
| 1999-12-31 | $209.19 Million | $-31.80 Million | -0.152x | -20.34% |
| 1998-12-31 | $246.20 Million | $-31.10 Million | -0.126x | -270.90% |
| 1997-12-31 | $276.00 Million | $-9.40 Million | -0.034x | +88.95% |
| 1996-12-31 | $130.80 Million | $-40.30 Million | -0.308x | -64.26% |
| 1995-12-31 | $85.30 Million | $-16.00 Million | -0.188x | -34.62% |
| 1994-12-31 | $105.50 Million | $-14.70 Million | -0.139x | -180.20% |
| 1993-12-31 | $49.50 Million | $8.60 Million | 0.174x | +243.91% |
| 1992-12-31 | $43.90 Million | $-5.30 Million | -0.121x | -152.08% |
| 1991-12-31 | $52.20 Million | $-2.50 Million | -0.048x | -- |